Skip to main content
. 2010 Aug 17;103(7):975–986. doi: 10.1038/sj.bjc.6605859

Figure 5.

Figure 5

Effect of COX-2 silencing mediated by InvColi-pS on CRC cell proliferation and viability. Cell number and cell viability were evaluated in (A, B) infected HT-29 and (C, D) HCA-7 cells, respectively. (): cells infected with InvColi-pS; (▪): cells infected with InvColi-pSH1; (▴): cells infected with InvColi-pSCOX−2; (): cells infected with InvColi-pSTBE. Viability was evaluated using the Trypan Blue exclusion assay and quantified as ((number of unstained cells)/(number of total cells)) × 100. Data represent mean±s.e.m. of three independent experiments. *P<0.01.